ANTIAGGREGANT THERAPY OVERCOMES LIMITS
Abstract
Antiaggregant therapy overcomes limits.
References
1. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 2002;324:71-86
2. COMMIT Collaborative Grioup. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomized placebo–controlled trial. Lancet 2005; 366: 1607-21
3. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation. N.England J.Med. 2005;352:1179-1189
4. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of schaemic events (CAPRIE). Lancet 1996;348:1329-1339
Review
For citations:
Andreeva I. ANTIAGGREGANT THERAPY OVERCOMES LIMITS. Rational Pharmacotherapy in Cardiology. 2009;5(5):93-95. (In Russ.)
Views:
555
Email this article 